LETTER: Put patients first in pharma debate
While I agree with Danny Rogers' comments about the pharma sector having to face its reputation demons (Leader, 14 March), research by Ipsos Mori and PricewaterhouseCoopers shows that the industry's reputation is not that terrible.
The pharma industry exists because of the patient. If patients stop taking their medicines and ignore GP and pharmacist advice, this places their health and even lives at risk.
I urge healthcare editors to think carefully about the impact of their articles on patients' welfare and to include helpline numbers and support websites.
ADVERTISEMENT
Kunal Mehta, PR lecturer, pharma responsibility and reputation conference director, Thames Valley University.
More like this
- Paul Holmes
- AT A GLANCE: ABPI offers guidelines on new research data
- James to face select committee
- NEWS ANALYSIS: Are blogs damaging pharma firms?
- Ethical Healthcare: Under the microscope
- Drugs firms must 'nurture' doctors
- Healthcare specialists hit back at damning web report
- Opinion: Irony of pharmas' saint and sinner status
- Healthcare: At a Glance - The UK Social Investment Forum (UKSIF)
Tags
Jobs
- Head of Learner Gateway and Communications
- £65k + excellent benefits
- Senior Account Manager or Account Director
- £30k - £45k + bens + bonus
- Director of Marketing
- £47,250 - £53,500
- Account Manager
Comments